Literature DB >> 21830274

DNA methylation of colon mucosa in ulcerative colitis patients: correlation with inflammatory status.

Shunsuke Saito1, Jun Kato, Sakiko Hiraoka, Joichiro Horii, Hideyuki Suzuki, Reiji Higashi, Eisuke Kaji, Yoshitaka Kondo, Kazuhide Yamamoto.   

Abstract

BACKGROUND: Although DNA methylation of colonic mucosa in ulcerative colitis (UC) has been suggested, the majority of published reports indicate the correlation between methylation of colon mucosa and occurrence of UC-related dysplasia or cancer without considering the mucosal inflammatory status. The aim of this study was to verify whether mucosal inflammation-specific DNA methylation occurs in the colon of UC.
METHODS: Of 15 gene loci initially screened, six loci (ABCB1, CDH1, ESR1, GDNF, HPP1, and MYOD1) methylated in colon mucosa of UC were analyzed according to inflammatory status using samples from 28 surgically resected UC patients.
RESULTS: Four of six regions (CDH1, GDNF, HPP1, and MYOD1) were more highly methylated in the active inflamed mucosa than in the quiescent mucosa in each UC patient (P = 0.003, 0.0002, 0.02, and 0.048, respectively). In addition, when the methylation status of all samples taken from examined patients was stratified according to inflammatory status, methylation of CDH1 and GDNF loci was significantly higher in active inflamed mucosa than in quiescent mucosa (P = 0.045 and 0.002, respectively). Multiple linear regression analysis revealed that active inflammation was an independent factor of methylation for CDH1 and GDNF. DNA methyltransferase 1 and 3b were highly expressed in colon epithelial cells with active mucosal inflammation, suggesting their involvement in inflammation-dependent methylation.
CONCLUSIONS: Methylation in colonic mucosa of UC was correlated with mucosal inflammatory status, suggesting the involvement of methylation due to chronic active inflammation in UC carcinogenesis.
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21830274     DOI: 10.1002/ibd.21573

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  40 in total

1.  Unique patterns of CpG island methylation in inflammatory bowel disease-associated colorectal cancers.

Authors:  Alexandru V Olaru; Yulan Cheng; Rachana Agarwal; Jian Yang; Stefan David; John M Abraham; Wayne Yu; John H Kwon; Mark Lazarev; Steven R Brant; Michael R Marohn; David F Hutcheon; Noam Harpaz; Stephen J Meltzer; Yuriko Mori
Journal:  Inflamm Bowel Dis       Date:  2011-08-09       Impact factor: 5.325

2.  Differential DNA methylation patterns of homeobox genes in proximal and distal colon epithelial cells.

Authors:  Alan Barnicle; Cathal Seoighe; Aaron Golden; John M Greally; Laurence J Egan
Journal:  Physiol Genomics       Date:  2016-01-26       Impact factor: 3.107

Review 3.  Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin?

Authors:  Mariabeatrice Principi; Floriana Giorgio; Giuseppe Losurdo; Viviana Neve; Antonella Contaldo; Alfredo Di Leo; Enzo Ierardi
Journal:  World J Gastrointest Pathophysiol       Date:  2013-11-15

Review 4.  Epigenetic alterations in inflammatory bowel disease and cancer.

Authors:  Joo Mi Yi; Tae Oh Kim
Journal:  Intest Res       Date:  2015-04-27

5.  An integrated approach to identify causal network modules of complex diseases with application to colorectal cancer.

Authors:  Zhenshu Wen; Zhi-Ping Liu; Zhengrong Liu; Yan Zhang; Luonan Chen
Journal:  J Am Med Inform Assoc       Date:  2012-09-11       Impact factor: 4.497

6.  Epigenetic modulation of intestinal Na+/H+ exchanger-3 expression.

Authors:  Anoop Kumar; Pooja Malhotra; Hayley Coffing; Shubha Priyamvada; Arivarasu N Anbazhagan; Harish R Krishnan; Ravinder K Gill; Waddah A Alrefai; David P Gavin; Subhash C Pandey; Pradeep K Dudeja; Seema Saksena
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-11-22       Impact factor: 4.052

Review 7.  The IBD interactome: an integrated view of aetiology, pathogenesis and therapy.

Authors:  Heitor S P de Souza; Claudio Fiocchi; Dimitrios Iliopoulos
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-23       Impact factor: 46.802

8.  Colitic Cancer Develops Through Mutational Alteration Distinct from that in Sporadic Colorectal Cancer: A Comparative Analysis of Mutational Rates at Each Step.

Authors:  Toshiaki Tanaka; Takashi Kobunai; Yoko Yamamoto; Shigenobu Emoto; Koji Murono; Manabu Kaneko; Kazuhito Sasaki; Kensuke Otani; Takeshi Nishikawa; Kazushige Kawai; Keisuke Hata; Hiroaki Nozawa; Toshiaki Watanabe
Journal:  Cancer Genomics Proteomics       Date:  2017 Sep-Oct       Impact factor: 4.069

Review 9.  Epigenetics and the developmental origins of inflammatory bowel diseases.

Authors:  Richard Kellermayer
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

10.  Methylated eyes absent 4 (EYA4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect.

Authors:  John B Kisiel; Megan M Garrity-Park; William R Taylor; Thomas C Smyrk; David A Ahlquist
Journal:  Inflamm Bowel Dis       Date:  2013-09       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.